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Summary
Most splice-site mutations lead to a limited array of
products, including exon skipping, use of cryptic splice-
acceptor or -donor sites, and intron inclusion. At the
intron 8 splice-donor site of the COL1A1 gene, we iden-
tified a G1rA transition that resulted in the produc-
tion of several splice products from the mutant allele.
These included one in which the upstream exon 7 was
extended by 96 nt, others in which either intron 8 or
introns 7 and 8 were retained, one in which exon 8 was
skipped, and one that used a cryptic donor site in exon
8. To determine the mechanism by which exon-7 rede-
finition might occur, we examined the order of intron
removal in the region of the mutation by using intron/
exon primer pairs to amplify regions of the precursor
nuclear mRNA between exon 5 and exon 10. Removal
of introns 5, 6, and 9 was rapid. Removal of intron 8
usually preceded removal of intron 7 in the normal gene,
although, in a small proportion of copies, the order was
reversed. The proportion of abnormal products sug-
gested that exon 7 redefinition, intron 7 plus intron 8
inclusion, and exon 8 skipping all represented products
of the impaired rapid pathway, whereas the intron-8
inclusion product resulted from use of the slow intron
7–first pathway. The very low–abundance cryptic exon
8 donor site product could have arisen from either path-
way. These results suggest that there is commitment of
the pre-mRNA to the two pathways, independent of the
presence of the mutation, and that the order and rate
of intron removal are important determinants of the out-
come of splice-site mutations and may explain some un-
usual alterations.
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Introduction
Most human genes have introns that must be removed
precisely to create the mature mRNA that encodes the
protein product. One common molecular mechanism of
human genetic disease involves mutations at splice junc-
tions (Cooper et al. 1995). In mammals, most introns
have conserved 5′ (donor) and 3′ (acceptor) sequences
that flank exons, a short polypyrimidine tract adjacent
to the acceptor site, and a branch point sequence 18–40
nt from the acceptor dinucleotide (Hawkins 1988; Ber-
get 1995). Mutations in these sites can lead to exon
skipping, short deletions, or insertions in the mature
mRNA. In most models of splicing, the exons are as-
sumed to be independent, so that splicing of one intron
occurs without regard to surrounding events. For most
genes, however, the order of intron removal is unknown.
In the few genes with a small number of introns in which
the order of splicing has been examined, it is ordered
but not processive (Lang and Spritz 1987; Gudas et al.
1990; Kessler et al. 1993). That is, splicing does not
proceed unhindered from the 5′ end to the 3′ end of the
initial transcript. Instead, there are rapid and slow splic-
ing events that give rise to major and minor pathways.
Collagen genes are complex, and those that encode
the fibrillar proteins have 150 exons (Byers 1995).Many
mutations in these genes involve splice-consensus se-
quences (Kuivaniemi et al. 1997; Schwarze et al. 1997)
and lead to a variety of outcomes that depend, in part,
on the site of the change. We identified a point mutation
in the 5′ donor sequence of intron 8 of the COL1A1
gene. Unexpectedly, this mutation led to several splice
outcomes, one of which was redefinition of the upstream
exon 7. Current models would not ordinarily predict
such an event (see Robberson et al. [1990] as an ex-
ample), but, if the order of intron removal in the normal
gene and the nature of intron sequences are considered,
then the different products and their relative abundance
appear to reflect the major and minor splicing pathways
in this region. Thus, consideration of the order of intron
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Table 1
Sequence of Oligonucleotide Primers

















NOTE.—E indicates an exon sequence, I an intron sequence;
F (forward) indicates a sense strand–primer, R (reverse) an
antisense strand–primer. Underlined nucleotides indicate in-
troducedmismatches. Sequences were derived frompreviously
published genomic sequence of COL1A1 (D’Alessio et al.
1988; Bateman et al. 1994) and from our own sequencing
data (unpublished).




The proband was the product of an uncomplicated
pregnancy and had a normal body length at birth. Be-
tween 10 mo and 9 years of age, she sustained several
dozen spontaneous fractures to the bones of her legs,
hands, and feet. After age 9 years, the fracture frequency
decreased dramatically. She was growth-retarded at that
point, with a height of 112 cm, which corresponds to
her adult height. Her virtual cessation of growth was
attributed, in part, to progressive scoliosis and moderate
deformity of her lower extremities. Her mobility is re-
duced, and she spends most of her time in a wheelchair.
Her sclerae have remained grayish-blue throughout her
life. These clinical findings were thought to be consistent
with the diagnosis of moderately severe osteogenesis im-
perfecta type IV.
Cell Culture and Analysis of Collagenous Proteins
Dermal fibroblasts were obtained from explants of a
skin biopsy from the proband, with appropriate consent.
Growth and maintenance of cells, radiolabeling of col-
lagenous proteins, and analysis of pro-a chains and a
chains by SDS-PAGE were performed as described else-
where (Bonadio et al. 1985).
RNA Isolation
Total RNA or nuclear and cytoplasmic RNA were
prepared from cultured fibroblasts of the proband and
a control-cell strain by guanidinium thiocyanate-phenol-
chloroform extraction (Chomczynski and Sacchi 1987).
Nuclei and cytoplasm were separated by incubating the
scraped cell pellet in Triton X-100 buffer (140 mM
NaCl; 2 mM EDTA; 10 mM Tris, pH 7.4; 0.8% Triton
X-100; 2 mM MgCl2 ) for 5 min on ice, followed by
centrifugation for 10 min at 1000 g, 4C. The super-
natant contained the cytoplasmic components. The nu-
clear pellet was gently vortexed for 5 s, washed in Triton
X-100 buffer for 10 s, and centrifuged for 5 min under
the same conditions as described above. The supernatant
was discarded, and the pellet was saved to isolate nuclear
RNA.
Preparation of cDNA and Genomic DNA, and
Sequence Determination
All RNA preparations were treated with DNase I
(Boehringer Mannheim) for 20 min at 37C with the
incubation buffer recommended by the manufacturer.
After ethanol precipitation on dry ice for 15 min, cDNA
was synthesized with random hexamers as primers for
AMV-reverse transcriptase (Promega). COL1A1 cDNA
was amplified by PCR (Saiki et al. 1987) (denaturation
at 94.5C for 1.5 min, annealing at 67C for 2 min, and
extension at 72C for 2 min, for 32 cycles) with primers
located in exon 6 (E 6F) and exon 10 (E 10R) (table 1),
and the cDNA fragments were separated on 6% poly-
acrylamide gels. Extra PCR bands, derived from the
cDNA of the patient, were cut out from the gel and
reamplified. Prior to sequence determination by the di-
deoxy-chain termination method (Sanger et al. 1977)
with T7 polymerase (Sequenase version 2.0, US Bioch-
emicals), the PCR products were purified on a 1%–low-
melting-temperature agarose gel (NuSieve GTG agarose;
FMC). Genomic DNA was isolated from cultured fibro-
blasts by standard methods (Sambrook et al. 1989). The
PCR was performed with primers located in exon 7 (E
7F) and exon 9 (E 9R) (table 1), under the same con-
ditions used for the amplification of cDNA. The DNA
sequence was determined, as above, with the primers
used for amplification.
Isolation of Nuclear RNA and cDNA Synthesis
Fibroblasts from a control and from the patient were
grown to near confluence in six 150 mm tissue-culture
dishes in DMEM with 10% fetal bovine serum. The
medium was then replaced by serum-free DMEM, and
5 mg of Actinomycin D (Boehringer Mannheim) per mil-
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Figure 1 PCR primers used for the determination of the order
of adjacent intron removal. (The schematic is drawn to scale.)
Figure 2 SDS-PAGE of radiolabeled procollagens (A) and col-
lagens (B) from medium and fibroblast cell layer. C  control; P 
proband. Procollagens were analyzed under reducing conditions; col-
lagens were generated by partial proteolysis with pepsin and separated
without reduction. The arrow points at a population of a1(I) chains
of faster-than-normal electrophoretic mobility that is retained
intracellularly.
liliter was added to halt transcription. The incubation
was terminated after 5 min, 10 min, 20 min, 40 min,
or 65 min by repeated rinse with ice-cold 1 # PBS to
inhibit nuclear mRNA export (Jarmolowski et al. 1994).
One dish of each cell line was left untreated to serve as
a baseline control. Isolation of nuclear and cytoplasmic
RNA from the different timepoints, treatment with
DNase I, and preparation of cDNA were performed as
described above. The cDNA was synthesized in a 20-ml
reaction volume, with 80% of the RNA preparation de-
rived for each timepoint. To check for residual genomic
DNA in the RNA preparation, one PCR reaction was
done without prior reverse transcription. To be sure that
there was no significant transfer of nuclear RNA into
the cytoplasmic fraction during the separation proce-
dure, we examined the presence of pre-mRNA in DNase
I–treated RNA preparations from both cellular com-
partments by amplification of the respective cDNA with
two intron primers derived from COL3A1 genomic se-
quence (Zafarullah et al. 1990).
Determination of the Order of Intron Removal
To determine the order of intron removal between
exon 5 and exon 10 ofCOL1A1 pre-mRNA, the splicing
intermediates were analyzed by a PCR strategy described
by Kessler et al. (1993). In brief, to determine the order
of splicing of two adjacent introns, two sets of staggered
primer pairs were used, each consisting of an exon and
an intron primer—the latter being crucial to amplifica-
tion of pre-mRNA in the presence of the predominant
mature mRNA. By extending the sets of overlapping
primer pairs over the entire area of interest (fig. 1), the
order of intron removal could be inferred. The nucleo-
tide sequences of the primers depicted schematically in
figure 1 are listed in table 1. The order of removal of
introns 5 and 6 versus intron 7 was determined by use
of primers in exon 5 (E 5F) and intron 7 (I 7R). PCR
was performed in a 50-ml volume containing 2 ml of the
cDNA mixture, 5 ml of 10 # PCR buffer with 20 mM
MgCl2, 0.2 mM dNTPs, 1 U of Taq polymerase (Boeh-
ringer Mannheim), and 10 pmol of each primer. For all
reactions, the sense primer was end-labeled with
g[32P]ATP (3,000 Ci/mmol; Amersham) by T4 polynu-
cleotide kinase (New England BioLabs). Amplifications
were done through 27 cycles of denaturation at 94.5C
for 1.5 min, primer annealing at 67C for 2 min, and
primer extension at 72C for 2min. Primer combinations
E 6F/I 8R, E 7F/I 9R, E 7F/I 8R, and I 8F/E 10R (table
1, fig. 1) required an annealing temperature of 60C for
1.5 min. All PCR products (10-ml aliquots) were sepa-
rated on 6% polyacrylamide gels. The gels were dried,
and the radioactive bands were visualized by autora-
diography. Prior to these experiments, COL1A1 ge-
nomic DNA from control fibroblasts was amplified with
the entire set of primer pairs, to characterize the sizes
of the products.
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Figure 3 COL1A1 amplification products of cDNA derived
from DNase-treated nuclear and cytoplasmic RNA. C  control; P 
proband. The sense primer that annealed to exon 6 sequence (E 6F)
was endlabeled using g[32P]-ATP; the antisense primer (E 10R) re-
mained unlabeled. To improve resolution, separation was performed
in a denaturing 8% polyacrylamide gel. A sequencing reaction was
run on the same gel and served as a size standard. The abnormal
transcripts schematically shown on the right were verified by sequence
determination. The schematics are drawn to scale. Single horizontal
lines represent full-length introns; the double line denotes the retention
of 96 nt of intron 7, resulting in exon 7 redefinition; and the undulated
vertical line shows the truncation of exon 8. The asterisk indicates a
GrA transition at the 1 position of intron 8. H  heteroduplex.
Results
Analysis of Collagen Production by the Patient’s
Cultured Fibroblasts
Fibroblasts from the proband synthesized and secreted
normal amounts of type III procollagen, but the amount
of type I procollagen secreted into the medium was di-
minished (fig. 2A). The electrophoretic mobilities of the
pro-a1(I) and pro-a2(I) chains were not altered, nor was
there an appreciable amount retained in the cell layer.
After partial proteolysis with pepsin of the secreted and
intracellular collagens, the population of a1(I) chains
was heterogeneous (fig. 2B). There was a very small
amount of a1(I) chains, with slightly faster-than-normal
mobility, secreted into the medium and a larger amount
of a1(I) chains, with a more obvious increase inmobility,
retained intracellularly.
Characterization of Abnormal Transcripts of COL1A1
and Identification of the Gene Defect
The observed protein alterations and the lack of ov-
ermodification of the a chains suggested that the mo-
lecular defect was located near the 5′ end of the triple-
helix coding region of COL1A1. To identify the molec-
ular defect, total RNAwas reverse transcribed,COL1A1
mRNA was amplified with primers E 6F and E 10R
(table 1), and the products were separated by 6% PAGE.
Amplification of the control sample yielded a single frag-
ment of the expected size (241 bp). In the material from
the proband, there were several bands in addition to the
normal species. To identify the abnormal transcripts and
to determine their cellular distribution, nuclear and cy-
toplasmic RNA from a control and the proband were
reverse transcribed, and COL1A1mRNA was amplified
with g[32P]-ATP–end-labeled exon primer E 6F and un-
labeled primer E10R and was separated on a denaturing
8% polyacrylamide gel (fig. 3). The bands were excised
from the gel and reamplified with the initial primers,
and their DNA sequences were determined.
The most abundant abnormal transcript in the cells
of the proband retained the 5′ 96 nt of the 158-nt intron
7 and skipped the 54-nt exon 8. Export into the cyto-
plasm appeared to be unimpeded. There were three less
abundant abnormal transcripts. In the first, exon 8 was
skipped, and the product was exported to the cytoplasm.
In the second, intron 8 (163 nt) was retained, and, in
the third, both intron 7 and intron 8 were retained. The
latter two transcripts were seen exclusively in the nu-
cleus, and in both of these transcripts there was a single
GrA nucleotide change at the 1 position of intron 8.
In the nucleus there was an additional transcript, with
very low abundance, from which the last 26 nt of exon
8 were deleted. Both exported transcripts would produce
shortened proteins and no doubt are responsible for the
abnormal proteins identified.
Genomic DNAs of a control and of the proband were
amplified with primers in exon 7 (E 7F) and exon 9 (E
9R) (table 1) and were sequenced directly. The only se-
quence alteration found was the GrA transition at 1
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Figure 4 Normal and mutant DNA sequence of COL1A1. A,
The sequence of exons 7, 8, and 9 is shown in uppercase letters and
that of introns 7 and 8 in lowercase letters. The splice-donor–site
mutation in intron 8 (G1rA) is pointed out above the normal se-
quence. The underlined nucleotides represent cryptic splice-donor sites.
G-triplets between the constitutive and cryptic intron 7 splice-donor
sites are in bold. The deduced noncollagenous amino acid sequence
due to exon 7 redefinition is shown in italics. B, Schematic represen-
tation of part of the COL1A1 gene illustrating the GrA transition
mutation at the donor site of intron 8 in the mutant allele and the
resulting alternative splice pathways (diagonal lines). The highly con-
served GT dinucleotide is underlined in the sequence of cryptic donor
sites present in intron 7 and in exon 8. The aberrant mRNA transcripts
derived from the mutant allele are listed so that the most abundant is
at the top and the least abundant at the bottom. The three transcripts
in between were expressed at similar levels.
of the 5′ (donor) splice site in one allele of intron 8 (IVS
8 G1rA) (fig. 4). There was a cryptic donor splice site
within intron 7 (tg/g[97]taaga, where “/” denotes the
site of cleavage) of both the normal allele and the allele
that contained the intron 8 mutation. In the mutant al-
lele, this cryptic donor site was used in a portion of the
transcripts and resulted in the retention of 96 nt of intron
7 (redefinition of exon 7). The 96-nt insertion encoded
an in-frame polypeptide of 32 residues that did not have
the canonical Gly-X-Y repeat characteristic of the col-
lagen triple helix (fig. 4A). An additional cryptic donor
site within exon 8 (TG/GTGAGC) gave rise to trunca-
tion of exon 8 by 26 nt (fig. 4B).
The Order of Intron Removal
Although the abnormal mRNA transcripts were iden-
tified, it remained unclear why a donor-site mutation
induced the activation of a cryptic donor site in the up-
stream intron as the preferred alternative splice pathway,
and why this mutation caused “splice paralysis” with
nuclear accumulation of splice intermediates. One pos-
sibility was that the order of intron removal in this region
of the gene determined the selection of alternate donor
sites. To characterize the order of intron removal, several
intron/exon primer pairs were used to amplify cDNA
synthesized from nuclear RNA from cells treated with
Actinomycin D for different periods.
When we placed primers in intron 6 and exon 8, using
nuclear RNA from the control cells, the vast majority
of the amplified product at 0 min contained intron 6
and intron 7, and the minor product contained only
intron 6 (fig. 5A). There was virtually no transfer of the
label from the large to the small fragment over time,
which is consistent with removal of intron 6 prior to the
excision of intron 7 in most transcripts. If intron 7 were
removed first, the majority of radiolabel should be found
in the smaller fragment during the chase period. When
the primers were placed in exon 6 and intron 8, there
was transfer of the label from the largest fragment at 0
min to an intermediate fragment, from which intron 6
had been excised (fig. 5B). Although some label was
transferred to a fragment from which intron 7 had been
excised, the majority of the product was no longer de-
tectable, because the sequence of intron 8 was removed
prior to the removal of intron 7. Thus, in most tran-
scripts, the removal of intron 6 preceded the removal of
intron 8, which, in turn, preceded the excision of intron
7. When primers were placed in exon 7 and intron 8
(fig. 5C), there was some transfer of label from the large
to the small fragment, which is consistent with a minor
pathway in which intron 7 was removed first. The ma-
jority of label simply disappeared between 10 and 20
minutes, which is consistent with rapid excision of intron
8. The observation that intron 8 was removed prior to
the excision of intron 7 in the majority of transcripts
was further corroborated by placement of primers in
intron 7 and exon 9 (fig. 5D). As the amount of the full-
size fragment decreased over time, there was a concom-
itant increase in the amount of product from which in-
tron 8 had been excised. Removal of introns 5, 6, and
9 was rapid and preceded excision of intron 8 (data for
introns 5 and 9 not shown). These findings were best
explained by ordered intron removal in this region of
the COL1A1 allele products (fig. 6). In the major path-
way, introns 5, 6, and 9 were excised very rapidly, and
we could not determine the precise order of their re-
moval. Subsequently, intron 8 was removed, followed
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Figure 5 Relative order of removal of introns 6, 7, and 8 of COL1A1. Nuclear RNA was prepared from cultured fibroblasts after defined
time intervals of exposure to Actinomycin D, treated with DNase, reverse transcribed, amplified with intron-exon primer pairs (the sense primer
of which was radioactively endlabeled), and separated by PAGE. The splicing intermediates, visualized by autoradiography, are schematically
depicted to scale to the right. Arrows indicate the annealing sites of the amplification primers (table 1, fig. 1). A, Control: Intron 6 was excised
prior to the excision of intron 7 in most transcripts. B, Control: After the removal of intron 6, in the larger proportion of transcripts the excision
of intron 8 preceded the excision of intron 7. C, Control: The majority of label disappeared between 10 and 20 minutes, consistent with removal
of intron 8 prior to the removal of intron 7. Patient: Long-term retention of intron 8 following removal of intron 7. D, Control: Removal of
intron 8 prior to removal of intron 7 was the predominant pathway of intron excision. Patient: The majority of label remained unchanged due
to both intron 7 and intron 8 retention. (The intron 7 primer was placed within the 3′ 62 nucleotides and corresponds to primer I 7F′ in table
1 and fig. 1.)
by excision of intron 7. In the minor pathway, intron 7
removal preceded excision of intron 8.
When we studied cells from the patient, using primers
in exon 7 and intron 8 (fig. 5C), there was accumulation
of product with prolonged retention of intron 8 after
removal of intron 7, which corresponded to one of the
products retained in the nucleus. When an intron 7
primer placed within the 3′ 62 nt of the intron (to assure
that it would be removed in the course of normal splic-
ing) and an exon 9 primer were used (fig. 5D), a small
amount of label was lost, which is consistent with nor-
mal splicing, presumably of the normal allele. The ma-
jority of label, however, remained in the initial product
for the full duration of the chase, which indicated that
both intron 7 and intron 8 were retained, as was con-
firmed by sequence determination of the amplified prod-
uct. This corresponded to the other of the two retained
nuclear products.
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Figure 6 Minor and major pathway of intron removal between
exon 5 and exon 10 of the normal and mutant allele of COL1A1.
Excision of introns 5, 6, and 9 was rapid, and the precise order of
their removal could not be determined. In the major pathway (wide
arrow) intron 8 was removed prior to intron 7; in the minor pathway
(thin arrow) intron 7 removal preceded excision of intron 8. The dif-
ferent splice products derived from the mutant allele (the site of the
mutation is indicated by an asterisk) and their relative proportion
reflected splicing via the major and minor pathway and suggested
commitment of the pre-mRNA to the two pathways independent of
the presence of the mutation.
Discussion
Splice-donor–site mutations most commonly lead to
exon skipping, to use of cryptic sites within the down-
stream intron or an adjacent exon, or to intron inclusion
if the intron is small (Talerico and Berget 1990). Splice-
acceptor–site mutations often lead to the use of cryptic
acceptor sites within the downstream exon or, less fre-
quently, within the upstream intron (Cooper et al. 1995;
Robberson et al. 1990). In some instances, splice-accep-
tor–site mutations lead to exon skipping or (rarely) give
rise to inclusion of the upstream intron (e.g. Schwarze
et al. 1997). The abundance and stability of mRNA gen-
erated by the use of alternative sites depends on whether
the products are in-frame, whether they lead to pre-
mature termination codons within the coding sequences,
and whether the termination codon is succeeded by an
intron (Maquat 1996; Carter et al. 1996).
To initiate splicing, the 5′ splice-donor site, the branch
point, and the adjacent polypyrimidine tract of the 3′
splice-acceptor region are recognized by elements of the
spliceosome in a process in which commitment to splic-
ing occurs (Reed and Palandjian 1997). After the assem-
bly of the spliceosome, a complex set of activation steps
and rearrangements leads to scission, lariat formation,
3′-end cleavage, and ligation to juxtapose the coding
elements in the mature mRNA (Staley and Guthrie
1998). In most models of splicing (see Berget 1995, for
example), only the removal of single introns is consid-
ered, and the implicit assumption is that splicing occurs
in a generally 5′ to 3′ direction in the precursor mRNA
(Lang and Spritz 1983). If splicing is not processive, then
one or more regions of the precursor mRNA may con-
tain introns surrounded by large domains of already
spliced sequences. Under these circumstances, the avail-
able choices for the splicing machinery may be more
restricted or may require a more imaginative cellular
process to create an in-framemRNA in the face of donor-
or acceptor-site mutations. In those small genes that have
been studied, such as b-globin (Lang et al. 1985), rat a-
lactalbumin and murine interleukin-3 (Lang and Spritz
1987), thymidine kinase (Gudas et al 1990), and adenine
phosphoribosyltransferase and dihydrofolate reductase
(Kessler et al 1993), intron removal appears to be or-
derly, but not strictly processive, from the 5′ end to the
3′ end of the precursor mRNA. Furthermore, these stud-
ies indicate that there are major and minor pathways
with a preferred, but not absolute, order of intron re-
moval. There are no published data on the order of
intron removal in larger, more complex genes, like
COL1A1.
In the region of the normal COL1A1 gene encom-
passed by exons 5–10, we found that introns 5, 6, and
9 were removed quickly. Intron 8 was then usually
spliced before intron 7, although there was aminor path-
way in which intron 7 was removed first (fig. 6). In the
cells from the patient we describe here (and one previ-
ously described by Bateman et al. 1994), a splice-donor
mutation in intron 8 of the COL1A1 gene of type I
collagen had several effects: (1) redefinition of the up-
stream exon 7, in the absence of changes in the preceding
intron or in the sequence of either exon 7 or intron 7
itself; (2) skipping of exon 8; (3) use of a cryptic donor
site in exon 8; (4) inclusion of intron 8; and (5) retention
of both intron 7 and intron 8. This mutation might be
expected to skip exon 8 because of failure of exon def-
inition (Robberson et al. 1990). With a small intron,
inclusion might occur, and, on occasion, an alternative
donor site could be used within either the intron or the
preceding exon. Redefinition of the upstream exon does
not fit with most splicing models (Berget 1995). It does,
however, correspond to products that could be predicted
if the order of intron removal is considered.
Because of the speed with which the surrounding in-
trons are removed, in the precursor mRNA there is a
“large” exon upstream of exon 7, followed by intron 7,
exon 8, intron 8, and then spliced product of (at least)
exons 9 and 10. With a mutation in the constitutive
donor site of intron 8, the weak donor site within the
exon, the strong cryptic site within intron 7 and the
constitutive intron 7 donor site could attract U1 snRNP,
the first component of the 5′ complex (Michaud and
Reed 1993). If intron 7 is spliced first, then the only
splicing alternatives that involve intron 8 are the use of
the exon 8 cryptic donor site or intron inclusion (fig. 6).
In the molecules “committed” to the intron 8–first path-
way, several alternatives can be envisaged. Splice “pa-
ralysis” could lead to retention of both intron 7 and
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intron 8. Competition between the two strong splice-
donor sites in intron 7 would be expected to lead to
exon 7 redefinition (use of the cryptic site) or skipping
of exon 8 (use of the constitutive site). Use of the exon
8 cryptic donor site would give rise to exon truncation
(fig. 6). The relative abundance of all the splice products
in the cell strongly suggests that there is commitment of
the pre-mRNA to the two pathways, independent of the
presence of the mutation, and that each product is de-
rived primarily from one of the pathways.
Although the cryptic intron 7 donor site is used fre-
quently, the constitutive site remains active. One possible
explanation for its activity is the presence of several G-
triplets in the immediate downstream region (fig. 4A).
McCullough and Berget (1997) demonstrated the role
of these motifs in directing the splicing machinery to the
adjacent upstream sites, and Cogan et al. (1997) and
McCarthy and Phillips (1998) showed that deletion of
a single G from a G-triplet in intron 3 of the human-
growth-hormone gene led to skipping of the upstream
exon. An alternative possibility is that the relative length
of the binding tracts of U1 snRNA and U6 snRNA,
which can influence the efficiency of 5′ donor site splicing
(Murray and Jarrell 1999; Staley and Guthrie 1999),
permits competition between the two sites.
The factors that control the order of intron removal
are not clear. The rate of intron removal could be influ-
enced by the “strength” of the donor and acceptor sites,
whether there are alternative or cryptic sites within the
introns (or exons), the presence of splice enhancers or
suppressors, the presence of SR protein–binding sites, or
the size of adjacent intron/exon units and whether they
permit simultaneous occupancy by spliceosomes. The
extent to which these cis-acting elements contribute to
the order of intron removal will likely depend on how
accessible they are to trans-acting factors. Hence, RNA
conformation also needs to be considered.
Most splice-site mutations produce only a single out-
come, although few are subjected to the scrutiny em-
ployed here. There are a number of instances in which
the outcome of splice mutations can be complex, with
multiple products, and other instances in which the same
splice-site alteration (e.g., Kuivaniemi et al. 1990) in dif-
ferent introns may have different effects. From these in-
dicators, it seems likely that in those regions the involved
genes may, like the region of the COL1A1 gene studied
here, be processed through major and minor pathways
and that use of these pathways will explain the multiple
outcomes.
Although the possible outcomes of splice mutations
can be predicted, it is difficult to determine, on the basis
of sequence changes alone, which of one or more pos-
sible choices will be made. If the phenotype is known,
such prediction may be of little consequence. However,
as mutation analysis moves to genomic characterization
alone and predictive information is sought, it would be
helpful to have models that can predict splice outcome.
For example, in the COL1A1 gene, both the
IVS47G1rA and the IVS48G1rA would be ex-
pected to lead to exon skipping and produce the lethal
OI type II phenotype. Although the IVS47mutation does
just that (unpublished observations), the IVS48mutation
results in the OI type I phenotype, apparently because
the use of an alternative donor site leads to a frame shift
and an unstable mRNA (Willing et al. 1994). While it
is a tall order, a detailed analysis of splice order in com-
plex genes like COL1A1 may produce sufficient insight
to provide a predictive model that could be applied to
many genes in which knowledge of the effect of a splice-
site mutation would have implications for therapy or
counseling.
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